Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks. Rinaldi L, Perini P, Calabrese M, Gallo P Neurol Sci. 2009 Oct; 30 Suppl 2:S171-3. PMID: 19882369. Abstract CommentRecommendBookmarkWatch